Revati Shreeniwas
Präsident bei Revati, Inc.
Ursprung des Netzwerks ersten Grades von Revati Shreeniwas
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 9 | |
| Public Company | Pharmaceuticals: Major | 3 | |
Continuing Medical Education, Inc.
 Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Continuing Medical Education, Inc. is based in San Diego, CA. Part of The Nielsen Company (US) LLC, Continuing Medical Education, Inc. is a company that publishes medical magazines and journals. Continuing Medical Education was acquired by Miller Freeman, Inc., part of The Nielsen Company (US) LLC from July 18, 2000 on March 26, 1999 for $111 million.
2
| Subsidiary | Publishing: Books/Magazines | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Revati Shreeniwas
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
FLG Partners LLC
 FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
| Medical Association of Thailand | Director/Board Member | ||
| AMYRIS, INC. | Chemicals: Specialty | Director of Finance/CFO | |
| NEUROBIOLOGICAL TECHNOLOGIES, INC. | Biotechnology | Director of Finance/CFO | |
| Dalhousie University | College/University | Undergraduate Degree | |
| BELYSSE GROUP NV | Home Furnishings | Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of California San Diego | College/University | Doctorate Degree | |
| Yale University | College/University | Graduate Degree | |
| VISTAGEN THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Mahidol University | College/University | Doctorate Degree | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| The Royal College of Surgeons of Thailand | President | ||
| University of Hamburg | College/University | Doctorate Degree | |
| Chaophya Medical Center Co. Ltd. | Director/Board Member | ||
Chaophya Hospital Public Co. Ltd.
 Chaophya Hospital Public Co. Ltd. Hospital/Nursing ManagementHealth Services Chaophya Hospital Public Co. Ltd. owns and operates a hospital. It offers medical services such as heart, children, eye, obstetrics and gynecology, radiology imaging, internal medicine, surgery, spine and orthopedic, checkup, gastrointestinal and liver, dental, skin laser and aesthetic, diabetes, haemodialysis, cardiac rehabilitation, and fertility services. The company was founded in 1991 and is headquartered in Bangkok, Thailand. | Hospital/Nursing Management | Director/Board Member | |
| Prince Mahidol Award Foundation | Corporate Officer/Principal | ||
| Thai Center For Continuing Medical Education | Chairman | ||
| Siriraj Foundation | Corporate Officer/Principal | ||
| BANGKOK DUSIT MEDICAL SERVICES | Hospital/Nursing Management | Chairman | |
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Pharmaceuticals: Major | Director/Board Member | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman | |
SmartRent Technologies, Inc.
 SmartRent Technologies, Inc. Packaged SoftwareTechnology Services Smartrent Technologies, Inc. engages in the development of a property management software. Its SmartRent platform enables property managers control locks, lights, thermostats, and senors in vacant units and common areas for residents. The company was founded by Lucas Merwan Haldeman in 2016 and is headquartered in Scottsdale, AZ. | Packaged Software | Director of Finance/CFO | |
| SMARTRENT, INC. | Computer Communications | Director of Finance/CFO | |
| Rugen Therapeutics | Corporate Officer/Principal | ||
| University of Bath | College/University | Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Edinburgh | College/University | Doctorate Degree | |
The Royal College of Psychiatrists
 The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Financial Conglomerates | Corporate Officer/Principal | |
| AVADEL PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Somatocor Pharmaceuticals, Inc. | Founder | ||
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Biotechnology | Corporate Officer/Principal | |
EraGen Biosciences, Inc.
 EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Medical Specialties | Chief Executive Officer | |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Founder | |
| Georgetown University Medical Center | College/University | Corporate Officer/Principal | |
| University of Pittsburgh | College/University | Corporate Officer/Principal | |
| Starwise Therapeutics LLC | Chief Executive Officer | ||
| University of Illinois | College/University | Corporate Officer/Principal | |
| RHÖN-Innovations GmbH | Corporate Officer/Principal | ||
| RHÖN-KLINIKUM AG | Hospital/Nursing Management | Corporate Officer/Principal | |
| PROSIEBENSAT.1 MEDIA SE | Movies/Entertainment | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 27 |
| Thailand | 10 |
| Vereinigtes Königreich | 7 |
| Deutschland | 5 |
| Dänemark | 3 |
Sektoral
| Health Technology | 15 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Health Services | 4 |
| Process Industries | 2 |
Operativ
| Corporate Officer/Principal | 32 |
| Director/Board Member | 28 |
| Director of Finance/CFO | 14 |
| Chairman | 12 |
| Independent Dir/Board Member | 10 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Revati Shreeniwas
- Unternehmensverbindungen
